$PLUR
Pluri Inc. Stock $plur

$plur Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-Q Financial Statement

#000117891316004191 Filed on February 08, 2016

Income Statement

Concept	2016 Q1	2015 Q4	2015 Q2
Revenue	$0.00	$2.752M	$90.00K
YoY Change	-100.0%	2796.84%	0.0%
Cost Of Revenue	$0.00	$97.00K	$0.00
YoY Change		2325.0%
Gross Profit	$0.00	$2.655M	$90.00K
YoY Change	-100.0%	2817.58%	0.0%
Gross Profit Margin		96.48%	100.0%
Selling, General & Admin	$1.640M	$1.550M	$1.740M
YoY Change	7.19%	2.65%	-25.64%
% of Gross Profit		58.38%	1933.33%
Research & Development		$5.571M
YoY Change		3.45%
% of Gross Profit		209.83%
Depreciation & Amortization	$560.0K	$530.0K	$570.0K
YoY Change	12.0%	6.0%	18.75%
% of Gross Profit		19.96%	633.33%
Operating Expenses	$7.400M	$5.571M	$5.910M
YoY Change	19.7%	3.45%	-13.22%
Operating Profit	-$7.400M	-$4.228M	-$5.820M
YoY Change	-1.71%	-32.9%	-13.39%
Interest Expense	$220.0K	$100.0K	$440.0K
YoY Change	120.0%	66.67%	-15.38%
% of Operating Profit
Other Income/Expense, Net	-$30.00K	$266.0K	$80.00K
YoY Change	-109.9%	375.0%
Pretax Income	-$7.200M	-$3.960M	-$5.300M
YoY Change	-0.41%	-36.64%	-14.52%
Income Tax
% Of Pretax Income
Net Earnings	-$7.200M	-$3.962M	-$5.300M
YoY Change	-0.36%	-36.56%	-14.52%
Net Earnings / Revenue		-143.97%	-5888.89%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.90	-$0.50	-$0.74
COMMON SHARES
Basic Shares Outstanding	79.93M shares		71.25M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q1	2015 Q4	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$37.43M	$43.10M	$52.04M
YoY Change	-8.91%	-4.73%	-3.47%
Cash & Equivalents	$5.400M	$4.948M	$22.63M
Short-Term Investments	$32.03M	$38.15M	$29.42M
Other Short-Term Assets	$1.520M	$1.530M	$2.058M
YoY Change	1.27%	47.12%	127.4%
Inventory
Prepaid Expenses			$919.0K
Receivables	$180.0K	$150.0K	$1.691M
Other Receivables	$0.00	$0.00	$621.0K
Total Short-Term Assets	$39.13M	$44.78M	$56.87M
YoY Change	-10.44%	-4.99%	-8.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.720M	$10.17M	$10.17M
YoY Change	-0.09%	-0.31%	-6.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$370.0K	$340.0K	$360.0K
YoY Change	8.82%	25.93%	20.0%
Other Assets	$770.0K	$750.0K	$1.000K
YoY Change	76900.0%	8233.33%	-87.5%
Total Long-Term Assets	$10.86M	$11.26M	$11.29M
YoY Change	1.05%	0.48%	-6.22%
TOTAL ASSETS
Total Short-Term Assets	$39.13M	$44.78M	$56.87M
Total Long-Term Assets	$10.86M	$11.26M	$11.29M
Total Assets	$49.99M	$56.04M	$68.16M
YoY Change	-8.17%	-3.94%	-7.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.970M	$1.835M	$3.268M
YoY Change	-17.75%	-27.24%	-5.69%
Accrued Expenses	$1.160M	$1.277M	$910.0K
YoY Change	75.49%	88.63%	-0.55%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.810M	$4.612M	$6.183M
YoY Change	-4.11%	-10.84%	-16.41%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.070M	$1.219M	$502.0K
YoY Change	295.79%	124.08%	-14.63%
Total Long-Term Liabilities	$2.070M	$2.080M	$3.829M
YoY Change	-46.46%	-48.36%	-14.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.810M	$4.612M	$6.183M
Total Long-Term Liabilities	$2.070M	$2.080M	$3.829M
Total Liabilities	$6.880M	$6.692M	$10.01M
YoY Change	-22.54%	-27.27%	-15.87%
SHAREHOLDERS EQUITY
Retained Earnings		-$148.3M	-$138.5M
YoY Change		17.75%	21.68%
Common Stock		$1.000K	$1.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$43.11M	$49.35M	$58.14M
YoY Change
Total Liabilities & Shareholders Equity	$49.99M	$56.04M	$68.16M
YoY Change	-8.17%	-3.94%	-7.93%

Cashflow Statement

Concept	2016 Q1	2015 Q4	2015 Q2
OPERATING ACTIVITIES
Net Income	-$7.200M	-$3.962M	-$5.300M
YoY Change	-0.36%	-36.56%	-14.52%
Depreciation, Depletion And Amortization	$560.0K	$530.0K	$570.0K
YoY Change	12.0%	6.0%	18.75%
Cash From Operating Activities	-$5.590M	-$3.620M	-$5.020M
YoY Change	-14.79%	-35.01%	-6.17%
INVESTING ACTIVITIES
Capital Expenditures	$70.00K	$360.0K	$190.0K
YoY Change	-22.22%	28.57%	46.15%
Acquisitions
YoY Change
Other Investing Activities	$6.100M	-$1.870M	$3.060M
YoY Change	-24.13%	-128.86%	-46.78%
Cash From Investing Activities	$6.050M	-$2.240M	$2.870M
YoY Change	-23.9%	-136.13%	-48.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	15.83M
YoY Change	-100.0%	-100.0%	2538.33%
NET CHANGE
Cash From Operating Activities	-5.590M	-3.620M	-5.020M
Cash From Investing Activities	6.050M	-2.240M	2.870M
Cash From Financing Activities	0.000	0.000	15.83M
Net Change In Cash	460.0K	-5.860M	13.68M
YoY Change	-76.88%	-554.26%	1509.41%
FREE CASH FLOW
Cash From Operating Activities	-$5.590M	-$3.620M	-$5.020M
Capital Expenditures	$70.00K	$360.0K	$190.0K
Free Cash Flow	-$5.660M	-$3.980M	-$5.210M
YoY Change	-14.89%	-31.97%	-4.93%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1076000	USD
CY2015Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	21636000	USD
CY2015Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	981000	USD
CY2015Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	2058000	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	550000	USD
CY2015Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	502000	USD
CY2015Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2080000	USD
CY2015Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3829000	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2015Q4	us-gaap	Assets Current AssetsCurrent	44782000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	56868000	USD
CY2015Q4	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	749000	USD
CY2015Q2	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	753000	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10173000	USD
CY2015Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	11259000	USD
CY2015Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	11287000	USD
CY2015Q4	us-gaap	Assets Assets	56041000	USD
CY2015Q2	us-gaap	Assets Assets	68155000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1835000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1277000	USD
CY2015Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	910000	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		USD
CY2015Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	379000	USD
CY2015Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent		USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4948000	USD
CY2015Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1500000	USD
CY2015Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1533000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4612000	USD
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6183000	USD
CY2015Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2468000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22626000	USD
CY2015Q2	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	859000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1219000	USD
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79736404	shares
CY2015Q4	us-gaap	Short Term Investments ShortTermInvestments	16517000	USD
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	78771905	shares
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	196929000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-148349000	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-138511000	USD
CY2015Q4	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock		USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	768000	USD
CY2015Q2	us-gaap	Short Term Investments ShortTermInvestments	7167000	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2140000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	49349000	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	58143000	USD
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79736404	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	78771905	shares
CY2011Q3	us-gaap	Licenses Revenue LicensesRevenue	7000000	USD
CY2011Q3	us-gaap	Revenue From Grants RevenueFromGrants	5000000	USD
	psti	Research And Development Milestone Revenue Receivable ResearchAndDevelopmentMilestoneRevenueReceivable	37500000	USD
	us-gaap	Reimbursement Revenue ReimbursementRevenue	10000000	USD
CY2013Q4	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	2500000	shares
CY2013Q4	psti	Available For Sale Marketable Securities Number AvailableForSaleMarketableSecuritiesNumber	1011504	shares
CY2013Q4	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	10414000	USD
CY2015Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	4825000	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1811900	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	451000	USD
CY2015Q4	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number Exercisable SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable	227250	shares
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-1346000	USD
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	26000	USD
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	20868000	USD
CY2015Q4	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1413000	USD
CY2015Q4	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax	645000	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	21636000	USD
CY2015Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	20156000	USD
CY2015Q2	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2255000	USD
CY2015Q2	us-gaap	Available For Sale Equity Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax	161000	USD
CY2015Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	22250000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	508000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	137000	USD
CY2015Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	107000	USD
CY2015Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	524000	USD
CY2015Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	54000	USD
CY2015Q4	psti	Warrants And Options Weighted Average Exercise Price Excercisable WarrantsAndOptionsWeightedAverageExercisePriceExcercisable	5.75
CY2015Q4	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	89000	USD
CY2015Q2	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	322000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-543000	USD
	psti	Percentage Of Qualified Expenditures PercentageOfQualifiedExpenditures	0.50	pure
	psti	Royalty Rate Payable On Grants Received RoyaltyRatePayableOnGrantsReceived	1.00	pure
CY2015Q4	us-gaap	Royalty Guarantees Commitments Amount RoyaltyGuaranteesCommitmentsAmount	21017000	USD
	psti	Warrants And Options Weighted Average Remaining Contractual Term Vested And Expected To Vest WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest	P2Y4M10D
CY2015Q4	psti	Warrants And Options Aggregate Intrinsic Value Vested And Expected To Vest WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest	147000	USD
CY2014Q4	psti	Stock Issued During Period Value Private Placement StockIssuedDuringPeriodValuePrivatePlacement	528000	USD
CY2015Q2	psti	Stock Issued During Period Shares Private Placement StockIssuedDuringPeriodSharesPrivatePlacement	300000	shares
CY2015Q2	psti	Stock Issued During Period Value Private Placement StockIssuedDuringPeriodValuePrivatePlacement	790000	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1836900	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	25000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.62
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1811900	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.77
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1811900	shares
	psti	Warrants And Options Weighted Average Remaining Contractual Term WarrantsAndOptionsWeightedAverageRemainingContractualTerm	P2Y4M10D
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-4228000	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.77
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y7M13D
CY2015Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	451000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10630000	USD
CY2015Q2	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	4000000	ILS
CY2015Q2	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	1032000	USD
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	3000000	ILS
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	774000	USD
	psti	Share Based Goods And Nonemployee Services Transaction Quantity Of Securities To Be Issued ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesToBeIssued	90000	shares
	us-gaap	Share Based Goods And Nonemployee Services Transaction Capitalized Cost ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost	302000	USD
CY2015Q4	psti	Warrants And Options Aggregate Intrinsic Value WarrantsAndOptionsAggregateIntrinsicValue	147000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11121000	USD
	dei	Entity Registrant Name EntityRegistrantName	PLURISTEM THERAPEUTICS INC
	dei	Document Period End Date DocumentPeriodEndDate	2015-12-31
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2016Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	79933902	shares
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Revenues Revenues	190000	USD
CY2015Q4	us-gaap	Revenues Revenues	2752000	USD
CY2014Q4	us-gaap	Revenues Revenues	95000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	100000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	7000	USD
CY2015Q4	us-gaap	Cost Of Revenue CostOfRevenue	97000	USD
CY2014Q4	us-gaap	Cost Of Revenue CostOfRevenue	4000	USD
	us-gaap	Gross Profit GrossProfit	183000	USD
CY2014Q4	us-gaap	Gross Profit GrossProfit	91000	USD
CY2015Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5571000	USD
CY2014Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5385000	USD
	psti	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	1165000	USD
	psti	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	2205000	USD
CY2014Q4	psti	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	506000	USD
	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	8916000	USD
CY2015Q4	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	5337000	USD
CY2014Q4	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	4879000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3033000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3191000	USD
CY2015Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1546000	USD
CY2014Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1513000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9751000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11924000	USD
CY2014Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-6301000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-87000	USD
CY2015Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	266000	USD
CY2014Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	56000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-9838000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12156000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-3962000	USD
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	-6245000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.12
CY2015Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
CY2014Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	79066675	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	69610528	shares
CY2015Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	79370673	shares
CY2014Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	70070509	shares
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-222000	USD
CY2014Q4	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	268000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3918000	USD
CY2015Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	425000	USD
CY2014Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	92000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	46000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	-156000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-626000	USD
CY2015Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	99000	USD
CY2014Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-171000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1372000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3358000	USD
CY2015Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	326000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11210000	USD
CY2014Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5915000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1372000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	USD
	psti	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	244000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1754000	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3358000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	49137000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	16000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1571000	USD
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	62123000	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	39000	USD
	us-gaap	Depreciation Depreciation	1031000	USD
	us-gaap	Depreciation Depreciation	1002000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		USD
	psti	Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities	146000	USD
	psti	Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities	145000	USD
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	197000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1571000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1754000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-1541000	USD
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-2105000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1032000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-772000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1051000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-417000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2847000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-190000	USD
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-104000	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	14000	USD
	psti	Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit	24000	USD
	psti	Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit	65000	USD
	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	6000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-9026000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1471000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	552000	USD
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	8794000	USD
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-11072000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	806000	USD
	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	-5000	USD
	us-gaap	Payments For Proceeds From Longterm Investments PaymentsForProceedsFromLongtermInvestments	-3000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	1054000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	2409000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	651000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	301000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	2513000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-11095000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	790000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	528000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	16000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	246000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2468000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4493000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6961000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	43000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	72000	USD
	us-gaap	Stock Issued1 StockIssued1	39000	USD
	us-gaap	Stock Issued1 StockIssued1		USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	17000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-181000	USD
CY2015Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	103000	USD
CY2014Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	59000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-139000	USD
CY2015Q4	us-gaap	Long Term Investments LongTermInvestments	340000	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	68155000	USD
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
	us-gaap	Use Of Estimates UseOfEstimates	<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <table style="font-family: times new roman; font-size: 10pt;" align="center" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr valign="top"> <td style="width: 18pt;"> <div><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">  </font></div> </td> <td style="width: 18pt;"> <div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">c.</font></div> </td> <td> <div align="left"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;"><font style="font-style: italic; display: inline; font-weight: bold;">Use of estimates</font></font></div> </td> </tr> </table> </div> <div style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;" align="justify"> </div> <div style="text-indent: 0pt; display: block; margin-left: 36pt; margin-right: 0pt;" align="justify"><font style="display: inline; font-family: Times New Roman; font-size: 10pt;">The preparation of financial statements in conformity with generally accepted accounting principles requires <font style="display: inline; font-size: 10pt;">management</font> to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</font></div> </div>
CY2015Q2	us-gaap	Long Term Investments LongTermInvestments	361000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10170000	USD
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3268000	USD
CY2015Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	93000	USD
CY2015Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1691000	USD
	us-gaap	Revenues Revenues	2847000	USD
CY2015Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent		USD
CY2015Q4	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	861000	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2015Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	195303000	USD
CY2015Q2	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	790000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	56041000	USD
CY2011Q3	us-gaap	Proceeds From Customers ProceedsFromCustomers	2000000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	10892000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	1192000	USD
CY2015Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	2535000	USD
CY2014Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	330000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15514000	USD
CY2015Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3636000	USD
CY2015Q4	psti	Aggregate Grants Received AggregateGrantsReceived	21183000	USD
CY2015Q4	psti	Royalties Amount Paid And Accrued RoyaltiesAmountPaidAndAccrued	166000	USD
CY2014Q4	psti	Stock Issued During Period Shares Private Placement StockIssuedDuringPeriodSharesPrivatePlacement	200000	shares
CY2015Q1	psti	Stock Issued During Period Shares Private Placement StockIssuedDuringPeriodSharesPrivatePlacement	200000	shares
CY2015Q1	psti	Stock Issued During Period Value Private Placement StockIssuedDuringPeriodValuePrivatePlacement	586000	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.72
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y7M13D
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Type DocumentType	10-Q
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	451000	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.77
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P1Y7M13D
CY2015Q2	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber	228000	shares
CY2015Q2	psti	Warrants And Options Weighted Average Exercise Price WarrantsAndOptionsWeightedAverageExercisePrice	5.73
	psti	Warrants And Options Weighted Average Remaining Contractual Term Exercisable WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable	P2Y4M2D
CY2015Q4	psti	Warrants And Options Aggregate Intrinsic Value Exercisable WarrantsAndOptionsAggregateIntrinsicValueExercisable	145000	USD
CY2015Q4	psti	Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number Vested And Expected To Vest SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest	228000	shares
CY2015Q4	psti	Warrants And Options Weighted Average Exercise Price Vested And Expected To Vest WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest	5.73
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-20000	USD
	dei	Entity Central Index Key EntityCentralIndexKey	0001158780
	us-gaap	Gross Profit GrossProfit	2747000	USD
CY2015Q4	us-gaap	Gross Profit GrossProfit	2655000	USD
CY2015Q4	psti	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	234000	USD
	psti	Research And Development Expenses Net ResearchAndDevelopmentExpensesNet	9465000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-232000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1346000	USD
CY2014Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	201000	USD
	psti	Stock Issued During Period Value Private Placement StockIssuedDuringPeriodValuePrivatePlacement	528000	USD
	psti	Adjustments To Additional Paid In Capital Issuance Of Stock Private Placement AdjustmentsToAdditionalPaidInCapitalIssuanceOfStockPrivatePlacement	790000	USD
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	20000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	184000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-953000	USD
	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-93000	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	39000	USD
	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-63000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7389000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	2543000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	10720000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	774000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-17678000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	132000	USD

Files In Submission

Name	View Source	Status
0001178913-16-004191-index-headers.html	Edgar Link	pending
0001178913-16-004191-index.html	Edgar Link	pending
0001178913-16-004191.txt	Edgar Link	pending
0001178913-16-004191-xbrl.zip	Edgar Link	pending
exhibit-31_1.htm	Edgar Link	pending
exhibit-31_2.htm	Edgar Link	pending
exhibit-32_1.htm	Edgar Link	pending
exhibit-32_2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
psti-20151231.xml	Edgar Link	completed
psti-20151231.xsd	Edgar Link	pending
psti-20151231_cal.xml	Edgar Link	unprocessable
psti-20151231_def.xml	Edgar Link	unprocessable
psti-20151231_lab.xml	Edgar Link	unprocessable
psti-20151231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zk1617952.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLUR
Pluri Inc. Stock $plur

2016 Q1 Form 10-Q Financial Statement

#000117891316004191 Filed on February 08, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR Pluri Inc. Stock $plur

2016 Q1 Form 10-Q Financial Statement

#000117891316004191 Filed on February 08, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR
Pluri Inc. Stock $plur